Ttk Health Care Q4 Results
- BSE: 507747
- NSE: TTKHLTCARE
- ISIN: INE910C01018
- Sector: Biotechnology & Drugs
BSE
1,300.10
-29.20 (-2.20%)
-29.20 (-2.20%)Volume65.00
Updated: Tue 8 Jul, 2025 | 15:17:37
NSE
1,302.00-28.10 (-2.11%)
-28.10 (-2.11%)Volume3.71 K
Updated: Tue 8 Jul, 2025 | 15:29:38
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹190.36 Cr.(5.14%)
- Operating Profit₹3.97 Cr.(-56.34%)
- Profit After Tax₹16.15 Cr.(-11.62%)
- Operating Margin2.09%(-58.47%)
Note: Comparison is on YoY basis
Quarterly - Ttk Health Care Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 186.39 | 199.16 | -6.42% | 171.96 | 8.39% |
| Depreciation/ Amortization | 2.17 | 2.11 | 2.66% | 3.32 | -34.72% |
| Operating Income | 3.97 | 5.58 | -28.82% | 9.10 | -56.34% |
| Net Income | 16.15 | 16.73 | -3.49% | 18.27 | -11.62% |
| Other Operating Expenses Total | 54.45 | 60.60 | -10.14% | 52.41 | 3.89% |
| Net Income Before Taxes | 21.76 | 22.59 | -3.71% | 24.23 | -10.20% |
| Total Revenue | 190.36 | 204.74 | -7.03% | 181.06 | 5.14% |
| Selling/ General/ Admin Expenses Total | 36.40 | 38.43 | -5.27% | 32.24 | 12.90% |
| Diluted Normalized EPS | 14.51 | 11.84 | 22.55% | 12.93 | 12.22% |